Coronary AngiographyHypCorNCT02818101
Hypnosis Efficacy for the Prevention of Anxiety During a Coronary Angiography
A study testing Hypnosis session in people with Coronary Angiography, run by Centre Hospitalier Régional Metz-Thionville at 1 site in France.
Trial summary
The purpose of this study is to confirm the utility for hypnosis in the coronary angiographic examination. The technique would be an alternative to prevent the consumption of anesthesic drugs. Read more about this study
- Who is it for?
- Ages 18 years and older
- Conditions the study is for
- Coronary Angiography
- What is being tested?
- Hypnosis session
- Type of treatment
- Lifestyle or therapy programme
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 169 participants
- Where
- 1 siteFrance
- Study dates
- Mar 2016to May 2018
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
Who may be able to join
- adult
- coronary angiography scheduled with or without stenting
- registered with a social security scheme
- people informed clearly by the investigator
Who cannot join
- coronary angiography already performed
- not well french speaking and understanding
- with functional disabilities (mental disorder, ...)
- known background of schizophrenia
- deaf or hard of hearing
- patient under legally protection
Trial locations and contacts
1 site in 1 country.
About this study
The purpose of this study is to confirm the utility for hypnosis in the coronary angiographic examination. The technique would be an alternative to prevent the consumption of anesthesic drugs.
Read the detailed description
The coronary angiography is a medical imaging acquisition used in cardiology to highlight the coronary arteries after a coronary disease suspicion. According to an expert consensus it is performed under local anesthesia. Indeed the examination is quite painless, apart from the initial arterial puncture. Moreover, any patient chest pain must be detected during the examination to locate the guilty coronary injury. This is not possible with a patient under general anesthesia.
But, no general anesthesia may be a source of anxiety for patients, and the technique can be painful at several times: during the puncture, the exploration of probe into the winding, spastic or over-calcified arteries, or even during the dilation by the balloon swelling which obstructs downstream the artery.
The efficiency evaluation of the hypnosis made by INSERM in 2015 concludes that "the use of hypnosis during a surgical practice or during a medical or a interventional radiological act allows to reduce the consumption of sedative drugs and/or pain medication preoperatively".
The study hypothesis, is that hypnosis can contribute to a decreasing of anxiety and the pain for patients undergoing coronary angiography, and even a decreasing of complications due to a better control of hemodynamic (heart rate and blood pressure).
It could entail a better comfort for operator during the coronary angiography.
Primary objective :
To compare the initial anxiety state before the coronary angiographic performing scheduled for adults with no earlier coronary angiography, according to they will undergo a hypnotic session or not before the examination, with posthypnotic suggestions of self-hypnosis to make during the coronary angiography.
Secondary objective :
To compare between the two groups of patients:
- pain during and after the coronary angiography
- hemodynamic factors heart rate, blood pressure before and after the examination
- operator comfort
- use of sedative drugs, pain medication and local anesthesia
- outbreak of major and minor complications
Primary endpoint :
Anxiety measured using self-report questionnaire (STAI-Y-A ), before coronary angiography
Secondary endpoints :
Trait anxiety (STAI-Y-B questionnaire) State anxiety the eve of coronary angiography Pain before and during the coronary angiography : Visual Analog Scale (VAS) Heart rate and blood pressure before and after the coronary angiography Comfort for the operator of the angiography : Likert scale into 5 points (1 : the worst comfort, 5 : the best possible comfort) Dose of sedative drugs, pain medication and local anesthesia injected during the coronary angiography Outbreak of major complications during the coronary angiography (death, stroke, tamponade, hemorrhagic shock, anaphylactic shock against the imaging tracer, ventricular tachycardia or ventricular fibrillation, severe bradycardia) or minor complications (vagal reaction, hematoma at the puncture point, skin allergy)
Methodology :
Efficiency comparative study, randomized, simple-blind (angiography operator in blind), single center, routine clinical care Only one medical check per patient
Procedures :
When a patient is taken over in cardiology department the eve of a scheduled coronary angiography, the cardiologist purposes them to take part in this study.
If they accept, a first evaluation of anxiety (trait and state) is performed. The following day, before going to the coronary angiography room, the patients are splitted randomly into two groups :
- A group of patients which undergo a hypnotic session before examination with posthypnotic suggestions of self-hypnosis to be performed during the angiography. A medical prescription for anxiolytics can be made according to the patient clinical signs of anxiety
- Another group becomes only a prescription of anxiolytics according to the patient clinical signs of anxiety.
The State Anxiety is measured after the setting of the patient in the coronary angiography room, before performing the examination. The pain and the hemodynamic factors are measured during and after the coronary angiography. The comfort of operator is evaluated too.
The patients will be contacted by phone one month after the coronary angiography to evaluate their satisfaction with their medical care.
Patients number :
Assuming that the control group has a mean score of 50 (standard deviation 10) with STAI-Y A, and a clinically significant difference (from 5 points), 85 patients must be included in each group, so totally 170 patients.
Trial Duration :
Expected study start: first semester of 2016 Inclusion duration: 12 months Duration per patient: 1 mois Total study duration: 18 months (including the data analysis et the report of results)
Statistical Analysis:
- Primary objective: comparison of the mean scores STAI-Y A between the two groups (T test of Student), with adjustment on the potential factors of confusion (multiple linear regression)
- Secondary objective: comparison of the quantitative criteria (T tests of Student) and qualitative criteria (Fischer's exact test) between the two groups.
Expected Benefits :
Since coronary angiography is an invasive procedure without general anesthesia affecting a noble organ, this procedure could be anxiogenic and even psychologically traumatic emergency. Not practice under general anesthesia prevents potential risks for the patient, but anxiety, non-comfort and pain are existing. We think that hypnosis could improve the patient care psychologically and physically and for any invasive procedure.
In this case, fewer or no sedative drugs and pain medication will be necessary, and it would decrease their potential iatrogenesis, the patient care will be improved. It will be an alternative for patient to decrease their drugs consumption.
Quality Assurance Plan :
Data will be recorded in a Paper Case Report from medical records. The patients will undergo only one medical examination for the study. No follow-up is expected.
- Conditions
- Coronary Angiography
- Being tested
- Hypnosis session
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Hypnosis sessionBehavioural
| Study group | Role | What they receive |
|---|---|---|
| Control group | No intervention | No hypnosis session before the coronary angiography |
| Hypnotised group | Experimental | Hypnosis session before the coronary angiography Receives: Behavioral: Hypnosis session |
What is being measured
The primary outcome is the main question the study is designed to answer.
State Anxiety
Spielberger State-Trait Anxiety Inventory (STAI):
Measured: 1 day
Secondary outcomes (6)
Comfort for the operator of the angiography
Likert scale into 5 points
Measured: 1 day
Pain
visual analogue pain scale
Measured: 1 day
Heart rate
beats per minute (bpm)
Measured: 1 day
Blood pressure
mmHg
Measured: 1 day
Major complications
beats per minutes
Measured: 1 day
dose of sedative drugs
mg
Measured: 1 day
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted29 Jun 2016 (estimated)
- Study startMar 2016
- Primary completionJun 2017
- Study completionMay 2018
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (1)Papers the sponsor has linked to this study.
- Other trials for Coronary AngiographyStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Supportive care
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind
- Who is masked
- Investigator
- Enrolment
- 169 participants (actual)
Sponsor and investigators
- Lead sponsor
- Centre Hospitalier Régional Metz-Thionville
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT02818101
- Sponsor's protocol ID
- 2016-02-CHRMT
- Acronym
- HypCor
- Status last verified
- Mar 2016
- First submitted
- 30 Mar 2016
- Last updated
- 24 Jun 2026
- Results posted
- No
- Data monitoring committee
- No
Publications
Abensur Vuillaume L, Gentilhomme C, Weber S, Ouamara N, Bayard J, Valla M, Khalife K, Goetz C, Guler N. Effectiveness of Hypnosis for the Prevention of Anxiety During Coronary Angiography (HYPCOR study): a prospective randomized study. BMC Complement Med Ther. 2022 Nov 29;22(1):315. doi: 10.1186/s12906-022-03792-x.
PubMed 36447198
Study at a glance
From the registry record, last updated by the sponsor on 24 Jun 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Hypnosis Efficacy for the Prevention of Anxiety During a Coronary Angiography
- ClinicalTrials.gov ID
- NCT02818101
- Acronym / sponsor ID
- HypCor / 2016-02-CHRMT
- Conditions
- Coronary Angiography
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 169 participants (actual)
- Lead sponsor
- Centre Hospitalier Régional Metz-ThionvilleUniversity, hospital or other
- Study start
- Mar 2016 (actual)
- Primary completion
- Jun 2017 (actual)
- Study completion
- May 2018 (actual)
- First posted
- 29 Jun 2016 (estimated)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The purpose of this study is to confirm the utility for hypnosis in the coronary angiographic examination. The technique would be an alternative to prevent the consumption of anesthesic drugs.
Detailed description
The coronary angiography is a medical imaging acquisition used in cardiology to highlight the coronary arteries after a coronary disease suspicion. According to an expert consensus it is performed under local anesthesia. Indeed the examination is quite painless, apart from the initial arterial puncture. Moreover, any patient chest pain must be detected during the examination to locate the guilty coronary injury. This is not possible with a patient under general anesthesia.
But, no general anesthesia may be a source of anxiety for patients, and the technique can be painful at several times: during the puncture, the exploration of probe into the winding, spastic or over-calcified arteries, or even during the dilation by the balloon swelling which obstructs downstream the artery.
The efficiency evaluation of the hypnosis made by INSERM in 2015 concludes that "the use of hypnosis during a surgical practice or during a medical or a interventional radiological act allows to reduce the consumption of sedative drugs and/or pain medication preoperatively".
The study hypothesis, is that hypnosis can contribute to a decreasing of anxiety and the pain for patients undergoing coronary angiography, and even a decreasing of complications due to a better control of hemodynamic (heart rate and blood pressure).
It could entail a better comfort for operator during the coronary angiography.
Primary objective :
To compare the initial anxiety state before the coronary angiographic performing scheduled for adults with no earlier coronary angiography, according to they will undergo a hypnotic session or not before the examination, with posthypnotic suggestions of self-hypnosis to make during the coronary angiography.
Secondary objective :
To compare between the two groups of patients:
- pain during and after the coronary angiography
- hemodynamic factors heart rate, blood pressure before and after the examination
- operator comfort
- use of sedative drugs, pain medication and local anesthesia
- outbreak of major and minor complications
Primary endpoint :
Anxiety measured using self-report questionnaire (STAI-Y-A ), before coronary angiography
Secondary endpoints :
Trait anxiety (STAI-Y-B questionnaire) State anxiety the eve of coronary angiography Pain before and during the coronary angiography : Visual Analog Scale (VAS) Heart rate and blood pressure before and after the coronary angiography Comfort for the operator of the angiography : Likert scale into 5 points (1 : the worst comfort, 5 : the best possible comfort) Dose of sedative drugs, pain medication and local anesthesia injected during the coronary angiography Outbreak of major complications during the coronary angiography (death, stroke, tamponade, hemorrhagic shock, anaphylactic shock against the imaging tracer, ventricular tachycardia or ventricular fibrillation, severe bradycardia) or minor complications (vagal reaction, hematoma at the puncture point, skin allergy)
Methodology :
Efficiency comparative study, randomized, simple-blind (angiography operator in blind), single center, routine clinical care Only one medical check per patient
Procedures :
When a patient is taken over in cardiology department the eve of a scheduled coronary angiography, the cardiologist purposes them to take part in this study.
If they accept, a first evaluation of anxiety (trait and state) is performed. The following day, before going to the coronary angiography room, the patients are splitted randomly into two groups :
- A group of patients which undergo a hypnotic session before examination with posthypnotic suggestions of self-hypnosis to be performed during the angiography. A medical prescription for anxiolytics can be made according to the patient clinical signs of anxiety
- Another group becomes only a prescription of anxiolytics according to the patient clinical signs of anxiety.
The State Anxiety is measured after the setting of the patient in the coronary angiography room, before performing the examination. The pain and the hemodynamic factors are measured during and after the coronary angiography. The comfort of operator is evaluated too.
The patients will be contacted by phone one month after the coronary angiography to evaluate their satisfaction with their medical care.
Patients number :
Assuming that the control group has a mean score of 50 (standard deviation 10) with STAI-Y A, and a clinically significant difference (from 5 points), 85 patients must be included in each group, so totally 170 patients.
Trial Duration :
Expected study start: first semester of 2016 Inclusion duration: 12 months Duration per patient: 1 mois Total study duration: 18 months (including the data analysis et the report of results)
Statistical Analysis:
- Primary objective: comparison of the mean scores STAI-Y A between the two groups (T test of Student), with adjustment on the potential factors of confusion (multiple linear regression)
- Secondary objective: comparison of the quantitative criteria (T tests of Student) and qualitative criteria (Fischer's exact test) between the two groups.
Expected Benefits :
Since coronary angiography is an invasive procedure without general anesthesia affecting a noble organ, this procedure could be anxiogenic and even psychologically traumatic emergency. Not practice under general anesthesia prevents potential risks for the patient, but anxiety, non-comfort and pain are existing. We think that hypnosis could improve the patient care psychologically and physically and for any invasive procedure.
In this case, fewer or no sedative drugs and pain medication will be necessary, and it would decrease their potential iatrogenesis, the patient care will be improved. It will be an alternative for patient to decrease their drugs consumption.
Quality Assurance Plan :
Data will be recorded in a Paper Case Report from medical records. The patients will undergo only one medical examination for the study. No follow-up is expected.
Study design
- Primary purpose
- Supportive care
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind (investigator)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| Control group | No intervention | –No hypnosis session before the coronary angiography |
| Hypnotised group | Experimental | Behavioral: Hypnosis sessionHypnosis session before the coronary angiography |
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (4 listed)
- adult
- coronary angiography scheduled with or without stenting
- registered with a social security scheme
- people informed clearly by the investigator
Key exclusion criteria (6 listed)
- coronary angiography already performed
- not well french speaking and understanding
- with functional disabilities (mental disorder, ...)
- known background of schizophrenia
- deaf or hard of hearing
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Hypnosis session | Behavioural | Hypnotised group |
Primary outcome
State Anxiety
Time frame: 1 day
Spielberger State-Trait Anxiety Inventory (STAI):
6 secondary outcomes
Comfort for the operator of the angiography
Time frame: 1 day
Pain
Time frame: 1 day
Heart rate
Time frame: 1 day
Blood pressure
Time frame: 1 day
Major complications
Time frame: 1 day
dose of sedative drugs
Time frame: 1 day
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 24 Jun 2026.
- Results publication: PubMed 36447198Abensur Vuillaume L, Gentilhomme C, Weber S, Ouamara N, Bayard J, Valla M, Khalife K, Goetz C, Guler N. Effectiveness of Hypnosis for the Prevention of Anxiety During Coronary Angiography (HYPCOR study): a prospective randomized study. BMC Complement Med Ther. 2022 Nov 29;22(1):315. doi: 10.1186/s12906-022-03792-x.
Related trials for Coronary Angiography
Not yet recruiting
Effect of Stress Ball Use During Femoral Arterial Sheath Removal After Coronary Angiography
Femoral Arterial Sheath Removal, Stress Ball
Recruiting
Randomized Prospective Trial on the Cost-Effectiveness of Photon-Counting CT Versus Energy-Integrating Detector CT in Suspected Chronic Coronary Syndrome
Computed Tomography Angiography, Coronary Artery Disease
Active, not recruitingPhase 3
A Study of Inclisiran to Prevent Cardiovascular Events in High-risk Primary Prevention Patients.
Primary Prevention of Atherosclerotic Cardiovascular Disease
Not yet recruiting
Sirolimus-Coated Versus Paclitaxel-Coated Balloon for Recurrent Coronary In-Stent Restenosis After Prior Paclitaxel-Coated Balloon Treatment (SPRIT)
Coronary In-stent Restenosis, Coronary Artery Disease
Enrolling by invitation
The DANE-HEART Trial - Computed Tomography Coronary Angiography for Primary Prevention
Coronary Atherosclerosis and Other Heart Disease, Cardiovascular Diseases
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Hypnosis session in people with Coronary Angiography, run by Centre Hospitalier Régional Metz-Thionville at 1 site in France.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 4 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 24 Jun 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
State Anxiety (time frame: 1 day). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT02818101, which also lists 1 linked publication.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 24 Jun 2026.